Insider Stock Trading History of Schoeneck James A


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Schoeneck James A since year 2005. The trader's CIK number is 1420987. At the time of this reporting, Schoeneck James A is the Director of Fibrogen Inc . (stock ticker symbol FGEN). See this page for all insider trading activities at Fibrogen Inc .

Note that in the past Schoeneck James A also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Schoeneck James A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-03-07 FGEN Fibrogen Inc Option Ex 2,000 2.90 5,800
2019-03-07 FGEN Fibrogen Inc Sale 2,000 54.92 109,850
2019-02-07 FGEN Fibrogen Inc Option Ex 2,000 2.90 5,800
2019-02-07 FGEN Fibrogen Inc Sale 2,000 57.17 114,340
2019-01-07 FGEN Fibrogen Inc Option Ex 2,000 2.90 5,800
2019-01-07 FGEN Fibrogen Inc Sale 2,000 45.90 91,800
2018-10-30 FGEN Fibrogen Inc Option Ex 24,000 13.89 333,312
2018-07-03 FGEN Fibrogen Inc Option Ex 7,639 2.90 22,153
2018-07-03 FGEN Fibrogen Inc Sale 7,639 65.00 496,535
2018-06-22 FGEN Fibrogen Inc Option Ex 4,361 2.90 12,646
2018-06-22 FGEN Fibrogen Inc Sale 4,361 65.00 283,465
2016-03-18 DEPO Assertio Therapeutics, Inc Option Ex 30,483 5.42 165,217
2015-12-28 DEPO Assertio Therapeutics, Inc Option Ex 6,365 6.11 38,890
2015-09-29 DEPO Assertio Therapeutics, Inc Option Ex 63,561 6.44 409,332
2015-05-12 DEPO Assertio Therapeutics, Inc Option Ex 45,679 6.86 313,357
2014-12-19 DEPO Assertio Therapeutics, Inc Option Ex 40,700 8.36 340,252
2014-08-01 DEPO Assertio Therapeutics, Inc Option Ex 30,000 6.11 183,300
2014-05-09 DEPO Assertio Therapeutics, Inc Option Ex 30,000 4.53 135,750
2014-03-14 DEPO Assertio Therapeutics, Inc Sale 17,000 14.54 247,129
2013-12-02 DEPO Assertio Therapeutics, Inc Sale 17,192 8.40 144,447
2013-05-10 DEPO Assertio Therapeutics, Inc Buy 25,000 5.11 127,625
2012-08-07 DEPO Assertio Therapeutics, Inc Option Ex 15,000 1.49 22,350
2011-08-23 DEPO Assertio Therapeutics, Inc Buy 20,000 5.14 102,760

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schoeneck James A (Director of Fibrogen Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.